3Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM [J].Diabetes.1997,46:3～10.
4Hota misligil-GS, Budavari A, Murray D, et al. Reduce tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role tumor necrosis factor α[J]. J Clin Invest ,1994,94:1543～1549.
5Bastard JP, Maachi M, Nhieu JT van, et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro[J]. J Clin Endocrinol Metab, 2002; 87:2084～2089.
6Ookuma M, Ookuma K, York DA, et al. Effects of leptin on insulin secretion from isolated rat pancreatic islets[J]. Diabetes, 1998, 47:219～223.
7McTernan CL, Mc Ternan PG, Herte AL, et al. Resistin, central obesity, and type 2 diabetes[J]. Lancet, 2002, 359:46～47.
8Ravussin E. Energy metabolism in obesity. Studies in the Pima Indians[J]. Diabetes Care, 1993, 16(S1):232～238.
9Zimmet P. The pathogenesis and prevention of diabetes in adults. Genes, autoimmunity, and demography[J]. Diabetes Care, 1995, 18:1050～1064.
二级参考文献7
1WHO/NUT/NCD. Obesity: preventing and managing the global epidemic. Report of a WHO consultation of obesity, Geneva. WHO,1998,2-17.
2Hurbert HB, Feinleib M, McNamara PM, et al. Obesity is an independent risk factor for cardiovascular disease : a 26 year follow-up of participants in Framingham Heart Study. Circulation, 1983,67: 968-977.
3de Silva AM, Walder KR, Boyko EJ, et al. Genetic variation and obesity in Australian women: a prospective study. Obes Res, 2001,9:733-740.
4WHO/NUT/NCD, Obesity: Preventing and managing the global epidemic. Report of a WHO consultation on obesity, Geneva; WHO,1997,3-5.
